IE39999L - Pyrazole -4- acetic acid derivatives. - Google Patents

Pyrazole -4- acetic acid derivatives.

Info

Publication number
IE39999L
IE39999L IE741705A IE170574A IE39999L IE 39999 L IE39999 L IE 39999L IE 741705 A IE741705 A IE 741705A IE 170574 A IE170574 A IE 170574A IE 39999 L IE39999 L IE 39999L
Authority
IE
Ireland
Prior art keywords
aug
derivatives
pharmaceutical compositions
acid derivatives
pyrazole
Prior art date
Application number
IE741705A
Other versions
IE39999B1 (en
Original Assignee
Byk Lomberg Chem Fab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Lomberg Chem Fab Gmbh filed Critical Byk Lomberg Chem Fab Gmbh
Publication of IE39999L publication Critical patent/IE39999L/en
Publication of IE39999B1 publication Critical patent/IE39999B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1475806 Pharmaceutical compositions of 5- Halo-1, 3-diphenyl pyrazole-4-acetic acids BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 14 Aug 1974 [16 Aug 1973] 35740/74 Heading A5B [Also in Division C2] Pharmaceutical compositions comprising a compound of the formula I in which Ph 1 and Ph 2 are the same or different phenyl radicals in which the substituents thereon, where present, are not hydrolysable and halogen is a fluorine chlorine or bromine atom or their salts with organic or inorganic bases and a pharmaceutically acceptable medicament vehicle show anti-inflammatory, antipyretic and analgesic activity when administered orally, parenterally, topically or rectally. The compositions may also contain other inflammatory agents such as a corticosteroid, analgesics, particularly pyrazolone derivatives e.g. prednisolone and dexamethasone, muscle relaxants such as pyridazine derivatives and carbamates, antiulcerogenics, antiacid materials such as magnesium trisilicate and aluminium hydroxide, substances which encourage local blood circulation such as nicotinic acid derivatives and dimethyl sulphoxide, local anesthetics such as lidocain and vitamins. [GB1475806A]
IE1705/74A 1973-08-16 1974-08-15 New halogenopyrazole derivatives, a method for producing them and medicaments containing them IE39999B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (en) 1973-08-16 1973-08-16

Publications (2)

Publication Number Publication Date
IE39999L true IE39999L (en) 1975-02-16
IE39999B1 IE39999B1 (en) 1979-02-14

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1705/74A IE39999B1 (en) 1973-08-16 1974-08-15 New halogenopyrazole derivatives, a method for producing them and medicaments containing them

Country Status (18)

Country Link
JP (1) JPS5230515B2 (en)
AT (1) AT339892B (en)
BE (1) BE818912A (en)
CA (1) CA1048499A (en)
CH (1) CH601250A5 (en)
DE (2) DE2462459C3 (en)
DK (1) DK136953B (en)
ES (1) ES429247A1 (en)
FI (1) FI57584C (en)
FR (1) FR2240732B1 (en)
GB (1) GB1475806A (en)
IE (1) IE39999B1 (en)
LU (1) LU68238A1 (en)
NL (1) NL169070C (en)
NO (1) NO140733C (en)
SE (1) SE409454B (en)
YU (1) YU222474A (en)
ZA (1) ZA745252B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
FI57584B (en) 1980-05-30
DK136953C (en) 1978-05-29
FI242274A (en) 1975-02-17
AT339892B (en) 1977-11-10
SE7410419L (en) 1975-02-17
DE2462459A1 (en) 1977-04-07
BE818912A (en) 1975-02-17
LU68238A1 (en) 1975-05-21
NO140733B (en) 1979-07-23
CH601250A5 (en) 1978-06-30
DE2438779C3 (en) 1979-09-20
DE2438779B2 (en) 1979-01-25
ZA745252B (en) 1976-03-31
ES429247A1 (en) 1976-08-16
DE2462459C3 (en) 1979-10-04
SE409454B (en) 1979-08-20
FR2240732A1 (en) 1975-03-14
DK438174A (en) 1975-04-28
JPS5049278A (en) 1975-05-01
NL169070B (en) 1982-01-04
NL7410921A (en) 1975-02-18
FR2240732B1 (en) 1978-07-21
DE2438779A1 (en) 1975-02-27
JPS5230515B2 (en) 1977-08-09
DE2462459B2 (en) 1979-02-08
DK136953B (en) 1977-12-19
ATA671174A (en) 1977-03-15
FI57584C (en) 1980-09-10
CA1048499A (en) 1979-02-13
YU222474A (en) 1983-04-27
NO140733C (en) 1979-10-31
IE39999B1 (en) 1979-02-14
GB1475806A (en) 1977-06-10
NO742941L (en) 1975-03-17
NL169070C (en) 1982-06-01

Similar Documents

Publication Publication Date Title
US4016268A (en) Method of combatting gastric ulceration
GEP19960467B (en) Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts
ES431425A1 (en) M-phenoxyphenyl propionic acid derivatives and preparation thereof
IE40791L (en) Vincamine derivatives
GB1146139A (en) New 1-(3,5-dihalo-4-hydroxy-phenyl)-2-(aryloxy- or arylalkyl-isopropylamino)-propanols, process for their preparation and therapeutic composition containing same
IE39999L (en) Pyrazole -4- acetic acid derivatives.
US3139381A (en) Process of effecting diuresis with nitro disulfamylaniline compounds
GB1457484A (en) Acylamidocephalosporins
IE40893B1 (en) 1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents
Kawai et al. Anti-inflammatory, analgesic and antipyretic activities of 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284)
US3060090A (en) Pyrazolidine-quinazolone therapeutic composition
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1399469A (en) Amino derivatives of pyrazolopyridine ketones
EP0059031B1 (en) Analgesic and anti-inflammatory composition
IE36205B1 (en) Substituted biphenyls
GB1344663A (en) Isoindoline compounds
US4621085A (en) 2,4,7-triamino-6-phenylpteridine
GB1319197A (en) 3,4,5-trisubstituted benzoic acid derivatives and their uses
US3269909A (en) Analgesic methods and compositions of benzoic acid derivatives
US5232686A (en) Gastroprotective pharmaceutical preparations containing n-benzyl-n-((1s,5s)-6,6-dimethylbicyclo(3,1,1)-hept-2-ylethoxy-ethyl)-morpholinium salts
GB1497004A (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols and esters thereof and their preparation
GB1186061A (en) Benzonaphthyridine Derivatives
US3692827A (en) Derivatives of aminoalkanoic acids
US3726913A (en) Derivatives of aminoalkanoic acids
GB1223875A (en) Phenylbutazone derivatives